NCT05462496 2024-10-15Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerIcahn School of Medicine at Mount SinaiPhase 2 Recruiting25 enrolled
NCT06359275 2024-06-25PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence PatientsFudan UniversityPhase 2 Recruiting81 enrolled